Home
  • E-mailLaura.Minsaas@uib.no
  • Phone+47 55 97 64 44
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development. Genome Medicine. 15 pages.
  • Show author(s) (2023). Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer. JCO Precision Oncology (JCO PO). 10 pages.
  • Show author(s) (2020). Olaparib monotherapy as primary treatment in unselected triple negative breast cancer. Annals of Oncology. 1-10.
  • Show author(s) (2020). Assessment of tumor suppressor promoter methylation in healthy individuals. Clinical Epigenetics. 1-15.
  • Show author(s) (2018). White blood cell BRCA1 promoter methylation status and ovarian cancer risk. Annals of Internal Medicine. 326-334.
  • Show author(s) (2012). Filamin A-hinge region 1-EGFP: a novel tool for tracking the cellular functions of filamin A in real-time. PLOS ONE. 15 pages.
  • Show author(s) (2010). Filamin A binds to CCR2B and regulates its internalization. PLOS ONE. 14 pages.
  • Show author(s) (2005). Proteasome involvement in the degradation of the G(q) family of G alpha subunits. The FEBS Journal. 5365-5377.
Thesis at a second degree level
  • Show author(s) (2004). Monocyte chemoattractant protein-1 (MCP-1) receptor-interacting proteins.
Masters thesis
  • Show author(s) (2008). Construction of a fluorescent filamin A protein as a tool for studying in vivo interactions with chemokine receptors.
Doctoral dissertation
  • Show author(s) (2010). A Study of G Protein Pathways: Internalization and Degradation.

More information in national current research information system (CRIStin)